Caring for social complexity in nanomedicine

Nanomedicine

Volumn 10, Issue 20, 2015, Pages 3181-3193

  Schillmeier, Michael ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

care; culture of promise; experimentation; nanomedicine; public controversy; publics; social complexity

Indexed keywords

CELL REGENERATION; DRUG DELIVERY SYSTEM; FIELD EXPERIMENT; HEALTH CARE COST; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LABORATORY TEST; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; NANOMEDICINE; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SOCIAL COMPETENCE; PROCEDURES; PUBLIC OPINION;

HUMANS; NANOMEDICINE; PUBLIC OPINION;

EID: 84944190324     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.15.149     Document Type: Review

References (78)

1. Deleuze G, Guattari F. What is Philosophy? Verso Books, NY, USA (1994).
2. Barz M. Complexity and simplification in the development of nanomedicines. Nanomedicine (Lond.) 10(20), 3093-3097 (2015).
3. Luxenhofer R. Polymers and nanomedicine: considerations on variability and reproducibility when combining complex systems. Nanomedicine (Lond.) 10(20), 3109-3119 (2015).
4. Guchet X. What's in a word? The person of personalized (nano)medicine. Nanomedicine (Lond.) 10(20), 3167-3179 (2015).
5. Pierce R. Translational nanomedicine through the therapeutic window. Nanomedicine (Lond.) 10(21), doi:10.2217/NNM.15.168 (2015) (In press).
6. Ach JS, Lüttenberg B. Nanobiotechnology, Nanomedicine and Human Enhancement. Lit-Verlag, Berlin, Germany (2009).
7. Allhoff F, Lin P, Moor J, Weckert J. Nanoethics. The Ethical and Social Implications of Nanotechnology. Wiley, NJ, USA (2007).
8. Allhof F, Lin P. Nanotechnology & Society. Current and Emergent Ethical Issues. Springer, NY, USA (2009).
9. Schmid G, Brune H, Grünwald A et al. Nanotechnology. Assessment and Perspective. Springer, Berlin, Germany (2006).
10. Kaiser M, Kurath M, Maasen S, Rehmann-Sutter CH. Governing Future Technologies. Nanotechnologies and the Rise of an Assessment Regime. Springer, Dordrecht, The Netherlands (2010).
11. Kjolberg K, Wickson F (Eds). Nano Meets Macro: Social Perspectives on Nanoscaled Sciences and Technologies. Pan Stanford, Singapore (2010).
12. Schillmeier M. What ELSA/I makes big and small in nanotechnological research. In: Absence in Science, Security and Policy. From Research Agendas to Global Strategy. Rappert B, Balmer B (Eds). Palgrave Macmillan, Basingstoke, UK, 55-77 (2015).
13. Schummer J, Baird D. Nanotechnology Challenges. Implications for Philosophy, Ethics and Society. World Scientific, NJ, USA (2006).
14. Latour B. Reassembling the Social. An Introduction to Actor-Network Theory. Oxford University Press, Oxford, UK (2005).
15. Schillmeier M. Eventful Bodies. The Cosmopolitics of Illness.Ashgate, Farnham, UK (2014).
16. Schillmeier M, Domènech M. New Technologies and Emerging Spaces of Care. Ashgate, Farnham, UK (2010).
17. Puig de la Bellacasa M. Matter of care in technoscience: assembling neglected things. Soc. Stud. Sci. 41(1), 85-106 (2011).
18. Latour B. An Inquiry into Modes of Existence. An Anthropology of the Moderns. Harvard University Press, MA, USA, 46 (2013).
19. Latour B. An Inquiry into Modes of Existence. An Anthropology of the Moderns. Harvard University Press, MA, USA, 58 (2013).
20. Stengers I. Power and Invention. Situating Science. University of Minnesota Press, MN, USA, 12 (1997).
21. Serres M. Hermes IV Verteilung. Merve, Berlin, Germany (1993).
22. Ge Y, Li S, Wang S, Moore R. Nanomedicine. Springer, NY, USA (2014).
23. Webster TJ. Nanomedicine. Technologies and Applications. Woodhead, MS, USA (2012).
24. Tibbals HF. Medical Nanotechnology and Nanomedicine. CRC Press, FL, USA (2011).
25. Jain KK. The Handbook of Nanomedicine. Humana Press, NJ, USA (2010).
26. Malsch I, Emond C. Nanotechnology and Human Health. CRC Press, FL, USA (2014).
27. Roco MC, Bainbridge WS. Converging Technologies for Improving Human Performance. Nanotechnology, Biotechnology, Information Technology and Cognitive Science. Kluwer, Dordrecht, The Netherlands (2003).
28. Alexiou C (Ed.). Nanomedicine-Basic and Clinical Applications in Diagnostic and Therapy. Karger, Erlangen, Germany (2011).
29. Nordmann A. Enhancing material nature. In: Nano Meets Macro: Social Perspectives on Nanoscaled Sciences and Technologies. Kjolberg K, Wickson F (Eds). Pan Stanford, Singapore, 283-303 (2010).
30. U.S. Department of Health and Human Services. National Institutes of Health, National Cancer Institute Cancer Nanotechnology. Going Small for Big Advances. Cancer Diagnosis, Prevention, and Treatment. NIH Publication, MD, USA, 1 (2004).
31. Freitas R. Nanomedicine. Volume I: Basic Capabilities. Landes Bioscience, TX, USA, 17-18 (1999).
32. Etheridge ML, Campbell SA, Erdman AG, Haynes CL, Wolf SM, McCullough J. The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomedicine (Lond.) 9(1), 1-14 (2013).
33. Hehenberger M. Nanomedicine: Science, Business, and Impact. Pan Stanford, Singapore (2015).
34. Igarashi E. Nanomedicines and Nanoproducts: Applications, Dispositions, and Toxicology in the Human Body. CRC Press, London, UK (2015).
35. Jain KK. The Handbook of Nanomedicine (2nd Edition). Humana Press, NJ, USA (2012).
36. Kostaleros K. The emergence of nanomedicine. Nanomedicine (Lond.) 1(1), 1-3 (2006).
37. Whitehead AN. Science and the Modern World. The Free Press, NY, USA (1967).
38. Stengers I. The Invention of Modern Science. University of Minnesota Press, MN, USA (2000).
39. Latour B. Science in Action. How to Follow Scientists and Engineers Through Society. Harvard University Press, MA, USA (1987).
40. Drummond C. Replicability is not reproducibility: nor is it good Science. Presented at: Evaluation Methods for Machine Learning Workshop at the 26th ICML. Montreal, Canada, 14-18 June 2009.
41. Kraus WL. Do you see what I see? Quality, reliability, and reproducibility in biomedical research. Mol. Endocrinol. 28(3), 277-280 (2014).
42. Casadevall A, Fang FF. Reproducible science. Infect. Immun. 78(12), 4972-4975 (2010).
43. Bissell M. Reproducibility: the risks of the replication drive. Nature 503, 333-334 (2013).
44. Trouble at the lab. The Economist. www.economist.com/news/briefing
45. Latour B. An Inquiry into Modes of Existence. An Anthropology of the Moderns. Harvard University Press, MA, USA (2013).
46. PourGashtasbi G. Nanotoxicology and challenges of translation. Nanomedicine (Lond.) 10(20), 3121-3129 (2015).
47. Seok J, Warren HS, Cuenca AG et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl Acad. Sci. USA 110(9), 3507-3512 (2013).
48. Perrin S. Preclinical research: make mouse studies work. Nature 507, 423-425 (2014).
49. Michael M, Wainwright S, Williams C. Temporality and prudence: on stem cells as "phronesic things". Configurations 13, 373-394 (2005).
50. European Commission. Of mice and men-are mice relevant models for human disease? http://ec.europa.eu/research/health/pdf/summary
51. Birke L. Animal bodies in the production of scientific knowledge: modelling medicine. Body Soc. 18, 156-178 (2012).
52. Meiners S, Bölükbas DA. Lung cancer nanomedicine: potentials and pitfalls. Nanomedicine (Lond.) 10(21), doi: 10.2217/NNM.15.155 (2015) (In press).
53. Davies G. What is a humanized mouse? Remaking the species and spaces of translational medicine. Body Soc. 18, 126 (2012).
54. Leonard F, Collnot E, Lehr CM. A three-dimensional coculture of entercytes, monocytes and dendritic cells to model inflamed intestinal mucosa in vitro. Mol. Pharm. 7(6), 2103-2119 (2010).
55. Kuhn TS. The Structure of Scientific Revolutions. University of Chicago Press, IL, USA (1970).
56. Latour B. The Pasteurization of France. Harvard University Press, MA, USA (1988).
57. Schillmeier M. Science, cosmopolitics and the question of agency. Kant's Critique and Stenger's Event. In: Agency Without Actors? Rethinking Collective Action. Passoth JH, Peuker B, Schillmeier M (Eds). Routledge, NY, USA, 31-53 (2012).
58. Stengers I. Power and Invention. Situating Science. University of Minnesota Press, MN, USA, 85 (1997).
59. Stengers I. Power and Invention. Situating Science. University of Minnesota Press, MN, USA, 165 (1997).
60. Serres M., Hermes I. Kommunikation. Merve, Berlin, Germany (1991).
61. Stengers I. Power and Invention. Situating Science. University of Minnesota Press, MN, USA, 17 (1997).
62. Drexler KE. Machine-phase nanotechnology. Sci. Am. 285(3), 74-75 (2001).
63. Smalley RE. Of chemistry, love, and nanorobots. Sci. Am. 285(3), 76-77 (2001).
64. Drexler KE, Forrest D, Freitas RA et al. On physics, fundamentals, and nanorobots: a rebuttal to Smalley's assertion that self-replicating mechanical nanorobots are simply not possible. Institute for Molecular Manufacturing (2001). www.imm.org/publications/sciamdebate2/smalley/
65. Baum R, Drexler E, Smalley R. Nanotechnology: Drexler and Smalley make the case for and against 'molecular assemblers'. C&EN 81(48), 37-42 (2003).
66. Drexler KE. Engines of Creation: The Coming Era of Nanotechnology. Anchor Books, NY, USA, 63 (1986).
67. Drexler KE. Engines of Creation: The Coming Era of Nanotechnology. Anchor Books, NY, USA, 106 (1986).
68. Smalley RE. Of chemistry, love, and nanorobots. Sci. Am. 285(3), 76 (2001).
69. Rheinberger HJ. Towards a History of Epistemic Things: Synthesizing Proteins in the Test Tube. Stanford University Press, Singapore (1997).
70. Dewey J. The Public and Its Problems. An Essay in Political Inquiry. Penn State University Press, PA, USA (2012).
71. Whitehead AN. Modes of Thought. The Free Press, NY, USA (1968).
72. White Paper to the Horizon 2020 Framework Programme for Research and Innovation-recommendations from the nanomedicine community, ETP nanomedicine (2013). www.etp-nanomedicine.eu/public/press-documents
73. Callon M, Lascoumes P, Barthe Y. Acting in an Uncertain World. An Essay on Technical Democracy. MIT Press, MA, USA (2001).
74. Stengers I. Another science is possible. A plea for slow science. Inaugural Lecture Chair Willy Calewaert. Brussels, Belgium, 13 December 2011.
75. Marres N. Issues spark a public into being. A key but often forgotten point of the Lippmann-Dewey debate. In: Making Things Public: Atmospheres of Democracy. Latour B, Weibel P (Eds). MIT Press, MA, USA (2005).
76. Marres N, Rogers R. Recipe for tracing the fate of issues and their publics on the web. In: Making Things Public: Atmospheres of Democracy. Latour B, Weibel P (Eds). MIT Press, MA, USA (2005).
77. Latour B, Weibel P. Making Things Public: Atmospheres of Democracy. MIT Press, MA, USA (2005).
78. Schillmeier M, Luxenhofer R, Barz R. Quo vadis nanomedicine? Nanomedicine 9(14), 2083-2086 (2014).